Demo
Close Language Tab
Locate us
Languages
N
Norris Medicines Ltd Pharmaceuticals
(%)
  • NSE
  • BSE

Overview

  • BSE Code 524414
  • NSE Symbol
  • ISIN Demat INE744C01029
  • Book Value (₹) -14.79
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 17.58
  • P/E (TTM) 0.00
  • EPS (TTM) 0.00
  • Div Yield (%) 0.00

Performance

Today’s Low
Today’s High

52W Low
52W High

Open
Prev. Close
Volume

About Norris Medicines Ltd

Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91.

The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995.

The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups strategic emphasis and marketing strengths worldwide.

Founded: 1990
Managing Director: Vimal D Shah
Address: Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002,